Gabapentin
- Product NDC
- 60760-517
- 11-digit product format
- 607600517
- Labeler code
- 60760
- Product ID
- 60760-517_45c5dff2-daa0-8de8-e063-6394a90a542b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA205101
- Marketing category
- ANDA
- Marketing start
- 2021-07-06
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gabapentin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GABAPENTIN | 800 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6CW7F3G59X |
| Rxcui | 310434 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60760-517-30 | Gabapentin | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 3 |
| 60760-517-60 | Gabapentin | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | | 3 |
| 60760-517-90 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-517-30 | 60760051730 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-517-30) | 30 tablet | 2025-12-12 | | No | No | Current |
| 60760-517-60 | 60760051760 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-517-60) | 60 tablet | 2021-07-06 | 0000-00-00 | No | No | Current |
| 60760-517-90 | 60760051790 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-517-90) | 90 tablet | 2025-12-12 | | No | No | Current |